Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,199,007 papers from all fields of science
Search
Sign In
Create Free Account
maltose tetrapalmitate
Known as:
D-Glucose, 4-O-alpha-D-glucopyranosyl-, tetrahexadecanoate
, maltose tetrapalmitate (MTP)
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Glycolipids
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
1994
Review
1994
Angiogenesis and breast cancer.
Daniel F. Hayes
Hematology/Oncology Clinics of North America
1994
Corpus ID: 23686878
1993
1993
The effect of maltose tetrapalmitate (MTP) on prostate cancer growth in vivo and in vitro.
N. M. Nguyen
,
J. Lehr
,
C. Shelley
,
J. Andersen
,
K. Pienta
Anticancer Research
1993
Corpus ID: 24397266
Maltose tetrapalmitate (MTP), a non-toxic synthetic glycolipid analog of lipid A, has been shown to have antitumor activity in…
Expand
1989
1989
Prophylactic antiangiogenic tumor treatment.
P. Madarnas
,
O. Benrezzak
,
V. Nigam
Anticancer Research
1989
Corpus ID: 22602988
Complementary antitumor treatments are required to increase the cure rate achieved by surgery and/or radiotherapy by avoiding…
Expand
1988
1988
Prophylactic maltose tetrapalmitate and bacillus Calmette-Guerin immunotherapy of recurrent superficial bladder tumors: preliminary report.
E. Ibrahiem
,
M. Ghoneim
,
V. Nigam
,
C. Brailovsky
,
M. Elhilali
Journal of Urology
1988
Corpus ID: 13107413
1986
1986
Combined radiotherapy, chemotherapy, and maltose tetrapalmitate immunotherapy in the treatment of 4'dimethylaminoazobenzene-induced liver cancer.
V. Nigam
,
N. Brière
,
+4 authors
P. Madarnas
Anticancer Research
1986
Corpus ID: 39606938
Therapeutic effects of radiotherapy (R), chemotherapy, and maltose tetrapalmitate (MTP) immunotherapy alone and in combinations…
Expand
1985
1985
Combination of 60Co gamma-radiation, misonidazole, and maltose tetrapalmitate in the treatment of Dunning prostatic tumor in the rat.
R. Pageau
,
V. Nigam
,
+5 authors
M. Elhilali
International Journal of Radiation Oncology…
1985
Corpus ID: 30296372
1984
1984
Combined cyclophosphamide chemotherapy and maltose tetrapalmitate immunotherapy in the treatment of transplanted bladder and prostate carcinoma of the rat.
E. Ibrahiem
,
V. Nigam
,
C. Brailovsky
,
B. D. Backman
,
M. Elhilali
Cancer Research
1984
Corpus ID: 14862544
Chemoimmunotherapy in two animal models for urological cancers was studied. The models were Dunning R3327A prostatic carcinoma…
Expand
1984
1984
Adjuvant immunotherapy of N-[4(5-nitro-2-furyl)-2-thiazolyl]-formamide-induced bladder tumors.
E. Ibraheim
,
H. El Kappany
,
V. Nigam
,
C. Brailovsky
,
P. Madarnas
,
M. Elhilali
Anticancer Research
1984
Corpus ID: 24258133
The prophylactic effect of maltose tetrapalmitate (MTP), a newly developed non specific immunoadjuvant in preventing or delaying…
Expand
1983
1983
A comparative study of the intravesical MTP and BCG treatment of transplantable bladder cancer.
M. Elhilali
,
E. Ibrahim
,
V. Nigam
,
C. Brailovsky
,
P. Madarnas
Journal of Urology
1983
Corpus ID: 20551880
1980
1980
The antitumour activity of maltose tetrapalmitate compared with other immunoadjuvants, and its effectiveness after tumour surgery.
H. El Kappany
,
C. Chopra
,
V. Nigam
,
C. Brailovsky
,
M. Elhilali
British Journal of Cancer
1980
Corpus ID: 6186069
The effectivenss of maltose tetrapalmitate (MTP) as an antitumour immune adjuvant was verified by its comparison with other known…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE